• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体内源性受体通道 TRPC6 是 Notch 信号通路驱动脑胶质瘤生长和侵袭的关键介质。

Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.

机构信息

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Florida Hospital Cancer Institute, Orlando, Florida 32816, USA.

出版信息

Cancer Res. 2010 Jan 1;70(1):418-27. doi: 10.1158/0008-5472.CAN-09-2654. Epub 2009 Dec 22.

DOI:10.1158/0008-5472.CAN-09-2654
PMID:20028870
Abstract

Glioblastoma multiforme (GBM) is the most frequent and incurable type of brain tumor of adults. Hypoxia has been shown to direct GBM toward a more aggressive and malignant state. Here we show that hypoxia increases Notch1 activation, which in turn induces the expression of transient receptor potential 6 (TRPC6) in primary samples and cell lines derived from GBM. TRPC6 is required for the development of the aggressive phenotype because knockdown of TRPC6 expression inhibits glioma growth, invasion, and angiogenesis. Functionally, TRPC6 causes a sustained elevation of intracellular calcium that is coupled to the activation of the calcineurin-nuclear factor of activated T-cell (NFAT) pathway. Pharmacologic inhibition of the calcineurin-NFAT pathway substantially reduces the development of the malignant GBM phenotypes under hypoxia. Clinically, expression of TRPC6 was elevated in GBM specimens in comparison with normal tissues. Collectively, our studies indicate that TRPC6 is a key mediator of tumor growth of GBM in vitro and in vivo and that TRPC6 may be a promising therapeutic target in the treatment of human GBM.

摘要

多形性胶质母细胞瘤(GBM)是成人中最常见且无法治愈的脑肿瘤类型。缺氧已被证明可使 GBM 向更具侵袭性和恶性的状态发展。在这里,我们表明缺氧会增加 Notch1 的激活,进而在源自 GBM 的原代样本和细胞系中诱导瞬时受体电位 6(TRPC6)的表达。TRPC6 是侵袭性表型发展所必需的,因为 TRPC6 表达的敲低会抑制神经胶质瘤的生长、侵袭和血管生成。功能上,TRPC6 导致细胞内钙的持续升高,与钙调神经磷酸酶-活化 T 细胞核因子(NFAT)途径的激活偶联。钙调神经磷酸酶-NFAT 途径的药理学抑制可显著减少缺氧下恶性 GBM 表型的发展。临床上,与正常组织相比,GBM 标本中 TRPC6 的表达升高。总之,我们的研究表明,TRPC6 是体外和体内 GBM 肿瘤生长的关键介质,TRPC6 可能是治疗人类 GBM 的有前途的治疗靶点。

相似文献

1
Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.受体内源性受体通道 TRPC6 是 Notch 信号通路驱动脑胶质瘤生长和侵袭的关键介质。
Cancer Res. 2010 Jan 1;70(1):418-27. doi: 10.1158/0008-5472.CAN-09-2654. Epub 2009 Dec 22.
2
Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.TRPC6 通道在人神经胶质瘤 G2/M 期转换和发展中的基本作用。
J Natl Cancer Inst. 2010 Jul 21;102(14):1052-68. doi: 10.1093/jnci/djq217. Epub 2010 Jun 16.
3
Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.通过iTRAQ分析检测到的塌陷反应介导蛋白1的缺失,促进了表达突变型表皮生长因子受体III(EGFRvIII)的人类胶质瘤的侵袭。
Cancer Res. 2009 Nov 15;69(22):8545-54. doi: 10.1158/0008-5472.CAN-09-1778. Epub 2009 Nov 10.
4
Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.ASCL1的上调和Notch信号通路的抑制是进展性星形细胞瘤的特征。
Oncogene. 2005 Oct 27;24(47):7073-83. doi: 10.1038/sj.onc.1208865.
5
Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.人胶质母细胞瘤细胞中NDRG1的氧依赖性调控:体外和体内研究
Oncol Rep. 2009 Jan;21(1):237-46.
6
Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.表皮生长因子受体III型变体诱导的胶质瘤侵袭是通过富含肉豆蔻酰化丙氨酸的蛋白激酶C底物过表达介导的。
Cancer Res. 2009 Oct 1;69(19):7548-56. doi: 10.1158/0008-5472.CAN-08-4783. Epub 2009 Sep 22.
7
Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition.受体通道TRPC6在缺氧条件下调控人肝星状细胞的激活。
Exp Cell Res. 2015 Aug 1;336(1):66-75. doi: 10.1016/j.yexcr.2015.03.023. Epub 2015 Apr 4.
8
EphA2 as a novel molecular marker and target in glioblastoma multiforme.EphA2作为多形性胶质母细胞瘤中的一种新型分子标志物和靶点。
Mol Cancer Res. 2005 Oct;3(10):541-51. doi: 10.1158/1541-7786.MCR-05-0056.
9
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.糖蛋白非转移性黑色素瘤蛋白B,多形性胶质母细胞瘤患者潜在的分子治疗靶点。
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1970-82. doi: 10.1158/1078-0432.CCR-05-2797.
10
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.利用抑制性消减杂交技术鉴定胶质母细胞瘤与毛细胞型星形细胞瘤中差异表达的基因。
Oncogene. 2006 May 4;25(19):2818-26. doi: 10.1038/sj.onc.1209305.

引用本文的文献

1
TRP Channel Inhibition and NF-κB Pathway Suppression in Human Ependymal Tumor cell-line by Achillea Biebersteinii Aqueous Extract.千叶蓍水提取物对人室管膜瘤细胞系中TRP通道的抑制作用及NF-κB信号通路的抑制作用
Cell Biochem Biophys. 2025 Jul 31. doi: 10.1007/s12013-025-01852-w.
2
Ion channel modulator DPI-201-106 significantly enhances antitumor activity of DNA damage response inhibitors in glioblastoma.离子通道调节剂DPI-201-106显著增强了胶质母细胞瘤中DNA损伤反应抑制剂的抗肿瘤活性。
Neurooncol Adv. 2024 Nov 19;6(1):vdae187. doi: 10.1093/noajnl/vdae187. eCollection 2024 Jan-Dec.
3
Genomic, epigenomic and transcriptomic landscape of glioblastoma.
胶质母细胞瘤的基因组、表观基因组和转录组景观。
Metab Brain Dis. 2024 Dec;39(8):1591-1611. doi: 10.1007/s11011-024-01414-8. Epub 2024 Aug 24.
4
Multicenter integration analysis of TRP channels revealed potential mechanisms of immunosuppressive microenvironment activation and identified a machine learning-derived signature for improving outcomes in gliomas.多中心整合分析 TRP 通道揭示了免疫抑制微环境激活的潜在机制,并确定了一种基于机器学习的特征,可改善神经胶质瘤的预后。
CNS Neurosci Ther. 2024 Jul;30(7):e14816. doi: 10.1111/cns.14816.
5
Mechanobiological insight into brain diseases based on mechanosensitive channels: Common mechanisms and clinical potential.基于机械敏感通道的脑疾病的机械生物学研究进展:共同机制与临床潜力。
CNS Neurosci Ther. 2024 Jun;30(6):e14809. doi: 10.1111/cns.14809.
6
HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.HNRNPA2B1 稳定 NFATC3 水平,增强其与 FOSL1 的协同作用,从而介导 GBM 细胞中的血管生成拟态。
Cell Biol Toxicol. 2024 Jun 11;40(1):44. doi: 10.1007/s10565-024-09890-5.
7
Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy.Notch信号通路在胶质母细胞瘤恶性进展中的机制及靶向治疗
Biomolecules. 2024 Apr 15;14(4):480. doi: 10.3390/biom14040480.
8
Proton-sensing ion channels, GPCRs and calcium signaling regulated by them: implications for cancer.质子感应离子通道、G蛋白偶联受体及其调控的钙信号传导:对癌症的影响
Front Cell Dev Biol. 2024 Mar 5;12:1326231. doi: 10.3389/fcell.2024.1326231. eCollection 2024.
9
Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets.非编码 RNA 作为胶质母细胞瘤 Notch 信号通路的关键调控因子:诊断、预后和治疗靶点。
CNS Neurol Disord Drug Targets. 2024;23(10):1203-1216. doi: 10.2174/0118715273277458231213063147.
10
GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma.胶质母细胞瘤间充质转变中GPR56信号通路网络及其动力学
J Cell Commun Signal. 2023 Dec;17(4):1527-1535. doi: 10.1007/s12079-023-00792-5. Epub 2023 Nov 19.